JPS61204126A - 排卵誘起剤及びその製造法 - Google Patents
排卵誘起剤及びその製造法Info
- Publication number
- JPS61204126A JPS61204126A JP4193285A JP4193285A JPS61204126A JP S61204126 A JPS61204126 A JP S61204126A JP 4193285 A JP4193285 A JP 4193285A JP 4193285 A JP4193285 A JP 4193285A JP S61204126 A JPS61204126 A JP S61204126A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl acetate
- fraction
- ovulation
- ethanol
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 230000000624 ovulatory effect Effects 0.000 title abstract 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 121
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 16
- 238000010828 elution Methods 0.000 claims abstract description 11
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 230000016087 ovulation Effects 0.000 claims description 35
- 230000001939 inductive effect Effects 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 11
- ARYTXMNEANMLMU-UHFFFAOYSA-N 24alpha-methylcholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 ARYTXMNEANMLMU-UHFFFAOYSA-N 0.000 claims description 6
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 claims description 6
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 241000209205 Coix Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000010898 silica gel chromatography Methods 0.000 claims description 2
- -1 trans-ferulyl stigmastanol Chemical compound 0.000 claims 4
- 239000002024 ethyl acetate extract Substances 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 17
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000741 silica gel Substances 0.000 abstract description 9
- 229910002027 silica gel Inorganic materials 0.000 abstract description 9
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 abstract description 6
- 239000000470 constituent Substances 0.000 abstract 1
- 239000000469 ethanolic extract Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 13
- 238000004440 column chromatography Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000001568 sexual effect Effects 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- ARYTXMNEANMLMU-ATEDBJNTSA-N campestanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]2(C)CC1 ARYTXMNEANMLMU-ATEDBJNTSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000010903 husk Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 description 3
- 235000020985 whole grains Nutrition 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001555 benzenes Chemical group 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002031 ethanolic fraction Substances 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 239000009538 yokuinin Substances 0.000 description 2
- BPSNETAIJADFTO-UHFFFAOYSA-N 2-pyridinylacetic acid Chemical compound OC(=O)CC1=CC=CC=N1 BPSNETAIJADFTO-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 241000699673 Mesocricetus auratus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 241000981595 Zoysia japonica Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- RAKOKKNCCBUUMP-UHFFFAOYSA-N stigmastanol trans-ferulate Natural products C1CC2(C)C3CCC4(C)C(C(C)CCC(CC)C(C)C)CCC4C3CCC2CC1OC(=O)C=CC1=CC=C(O)C(OC)=C1 RAKOKKNCCBUUMP-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4193285A JPS61204126A (ja) | 1985-03-05 | 1985-03-05 | 排卵誘起剤及びその製造法 |
| US06/831,853 US4897224A (en) | 1985-03-05 | 1986-02-24 | Method for producing ferulyl stanol derivatives |
| CA000503235A CA1271139A (en) | 1985-03-05 | 1986-03-04 | Fertility drug and method of producing the same |
| EP86102817A EP0203277B1 (en) | 1985-03-05 | 1986-03-04 | Fertility drugs containing coix lacryma-jobi extracts or ferulyl stanol derivatives and/or a phytosterol fatty-acid ester |
| DE8686102817T DE3688001T2 (de) | 1985-03-05 | 1986-03-04 | Fruchtbarkeitsmittel enthaltend extrakte von coix lacryma-jobi oder ferulylstanolderivate und/oder fettsaeure-phytosterolester. |
| CA000610993A CA1288421C (en) | 1985-03-05 | 1989-09-11 | Fertility drug and method of producing the same |
| US07/433,289 US5023249A (en) | 1985-03-05 | 1989-11-08 | Fertility drug and method of producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4193285A JPS61204126A (ja) | 1985-03-05 | 1985-03-05 | 排卵誘起剤及びその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61204126A true JPS61204126A (ja) | 1986-09-10 |
| JPS6366809B2 JPS6366809B2 (enrdf_load_stackoverflow) | 1988-12-22 |
Family
ID=12622001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4193285A Granted JPS61204126A (ja) | 1985-03-05 | 1985-03-05 | 排卵誘起剤及びその製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61204126A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61204131A (ja) * | 1985-03-07 | 1986-09-10 | Morinaga Milk Ind Co Ltd | 排卵誘起剤 |
| JP2012518681A (ja) * | 2009-02-25 | 2012-08-16 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | フィトステリルフェルレートの製造方法 |
-
1985
- 1985-03-05 JP JP4193285A patent/JPS61204126A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61204131A (ja) * | 1985-03-07 | 1986-09-10 | Morinaga Milk Ind Co Ltd | 排卵誘起剤 |
| JP2012518681A (ja) * | 2009-02-25 | 2012-08-16 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | フィトステリルフェルレートの製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6366809B2 (enrdf_load_stackoverflow) | 1988-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5435375B2 (ja) | セスキテルペン誘導体の用途 | |
| JP2912537B2 (ja) | ククルビタ種の新規な抽出物、それらの製造方法、ならびに医薬品および化粧品におけるそれらの使用 | |
| JP2006111560A (ja) | セラミド合成促進剤 | |
| US6264928B1 (en) | Use of shogaols and gingerols for preparing deodorant compositions | |
| JP3968405B2 (ja) | 抗アレルギー剤 | |
| CN116606269A (zh) | 米团花二倍半萜化合物与提取物l01及其在制药中的应用 | |
| CN113209165A (zh) | 一种大叶蒟提取物及其制备方法与应用 | |
| JP6976014B1 (ja) | 新規ポリフェノール化合物 | |
| JP5354741B2 (ja) | 睡眠改善剤 | |
| JPS61204126A (ja) | 排卵誘起剤及びその製造法 | |
| WO2007079695A1 (fr) | Extrait de xanthoceras sorbifolia bunge et extraction et utilisation | |
| JPH10101561A (ja) | 脂肪細胞への細胞分化促進用組成物 | |
| KR100321313B1 (ko) | 류코트리엔생성저해활성을가지는신이추출물및신이로부터분리한리그난화합물 | |
| US7101913B2 (en) | Hepatic disorder suppressant | |
| JP4001395B2 (ja) | コレステロールアシルトランスフェラーゼ活性阻害剤及び組成物 | |
| JPH08310949A (ja) | アシルコエンザイムａ：コレステロールアシルトランスフェラーゼ阻害剤 | |
| JP4105498B2 (ja) | アトピー性疾患の症状の予防・緩和に有効な組成物 | |
| JPS64366B2 (enrdf_load_stackoverflow) | ||
| JP2816664B2 (ja) | 抗痴呆症剤 | |
| JP2020050593A (ja) | インターロイキン−３３産生抑制剤並びにインターロイキン−３３の増加に関連するアレルギー疾患の予防、治療又は抑制用の医薬品、医薬部外品、化粧料及び飲食品組成物 | |
| JP4080567B2 (ja) | 新規ステロイド化合物およびこれを有効成分とするインターロイキン４産生抑制剤 | |
| JPH0952899A (ja) | ロイコトリエン拮抗剤 | |
| JPH1045613A (ja) | インターロイキン４産生抑制剤 | |
| WO2003020254A1 (en) | Pharmaceutical composition comprising (-)-secoisolariciresinol | |
| JP2628832B2 (ja) | 新規タンニン |